Science Atlas

How We Know What We Know
Sign In
Text size
100%
Theme
Scientist

Carl Djerassi

Chemistry

Carl Djerassi (October 29, 1923 to January 30, 2015) was a Vienna-born chemist who emigrated to the United States and became an American citizen. In 1951, working at the Mexican pharmaceutical company Syntex, he led the team that synthesized norethisterone, the first orally active synthetic progestin, a compound that became a key ingredient of the first combined oral contraceptive pill and earned him lasting recognition as one of the fathers of the birth control pill. Beyond his chemistry, Djerassi later became a prolific novelist and playwright, using fiction to explore the culture and ethics of science.

Facts
Birth Year
1923 1
Death Date
2015-01-30 1
Death Year
2015 1
Death Place
San Francisco, United States 1
Nationality
Austria 1
Nationality
Bulgaria 1
Nationality
United States 1
Birthplace
Vienna, Austria 1
Field
Field (category)
Chemistry 1
Connections

Member Of

Source Carl Djerassi (Wikipedia)

Works In

Chemistry, Disciplines
Source Carl Djerassi (Wikipedia)
In the Other Atlases
Sources
1. Carl Djerassi (Wikidata)
  • P570 (date of death): year
    +2015-01-30T00:00:00Z
  • P570 (date of death): full date
    +2015-01-30T00:00:00Z
  • P27 (country of citizenship): Austria
    Q40
  • P20 (place of death): San Francisco, United States
    Q62
  • P27 (country of citizenship): United States
    Q30
  • P19 (place of birth): Vienna, Austria
    Q1741
  • P27 (country of citizenship): Bulgaria
    Q219
View the Source
Carl Djerassi (Wikipedia)
  • Works In: Chemistry, Lead sentence
    Carl Djerassi (October 29, 1923, January 30, 2015) was a Viennese-born Bulgarian-American pharmaceutical chemist, novelist, playwright and co-founder of Djerassi Resident Artists Program with Diane Wood Middlebrook.
  • Member Of: National Academy of Sciences, Categories
    Category:Members of the United States National Academy of Sciences
View the Source
Comments (0)
No comments yet. Be the first to share a thought.
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.